Several pharmaceutical companies are developing oral GLP-1 options for weight loss, which may significantly impact the industry. The debut of these pills is anticipated, with some reports suggesting that major companies such as Novo and Lilly are preparing to launch their own versions. The introduction of these weight loss pills is expected to be a notable development in the industry, but the exact timing and details of the launches are not yet clear.